Sleep Advice Is Everywhere. Answers Are Rare.
According to the Robert Koch Institut's DEGS1 study, roughly one third of German adults report clinically relevant problems initiating or maintaining sleep. The DAK Gesundheitsreport 2017 found that among employed adults aged 35 to 65, sleep problems have risen approximately 60% since 2010. One in ten now meets the full diagnostic criteria for an insomnia disorder.
Most of those people will try melatonin. Many will download a sleep app, invest in blackout curtains, or cut caffeine after noon. Some will read about sleep hygiene protocols and follow them faithfully for three weeks before giving up. Very few will ask their doctor for a blood test. And almost none will receive one.
This is the gap that the current healthcare model rarely addresses: when sleep disruption persists despite sensible behavioural changes, it usually has a measurable biological cause. Something in the body's hormonal, nutritional, or inflammatory system is dysregulated, and until that dysregulation is identified and corrected, no sleep protocol will fix it.
There is nothing wrong with the standard advice to reduce screen time, keep a consistent wake time, and avoid alcohol before bed. But it treats poor sleep as a behaviour problem when it is frequently a biology problem. The two are not mutually exclusive. The biology, however, comes first.
This article maps the five blood biomarkers most commonly implicated in chronic sleep disruption: what they do, how they go wrong, what the evidence says, and why none of them appear in the standard German blood panel.
The Five Biomarkers Most Commonly Driving Sleep Disruption
Cortisol: When Your Stress System Forgets When to Switch Off
Cortisol is not simply a stress hormone. It is your body's primary circadian signal. In a healthy pattern, cortisol spikes sharply in the first 30 minutes after waking, a pattern known as the Cortisol Awakening Response, then declines gradually through the day, reaching its lowest point around midnight. This rhythm is what makes you alert in the morning and sleepy at night. When the rhythm is intact, melatonin rises as cortisol falls. When the rhythm is disrupted, melatonin production is blunted, sleep onset is delayed, and the quality of sleep deteriorates even when its duration appears normal.
A 2017 study published in PMC examined the effects of chronic circadian misalignment on cortisol and inflammatory proteins in healthy adults. The researchers found that weeks of sustained circadian disruption significantly elevated cortisol and pro-inflammatory markers, and that even acute total sleep deprivation altered the cortisol curve in measurable ways.
The clinical picture that most commonly appears in practice looks like this: groggy for one to two hours after waking regardless of how long sleep lasted, a dependency on caffeine before 10am to reach functional alertness, a pronounced energy crash between 2pm and 4pm, and a paradoxical second wind that arrives after 9pm. This is the signature of a flattened cortisol curve. It is low when it should be high, and elevated when it should be falling.
The catch for standard testing is significant. A single morning cortisol blood draw, the only cortisol measurement routinely offered in a GP setting, captures one data point in what is fundamentally a rhythm. It can confirm severe adrenal dysfunction. It cannot detect a disrupted curve. Two people can have identical single-point cortisol readings and have entirely different diurnal patterns.
There is also a documented feedback loop that worsens over time: chronic sleep disruption flattens the cortisol curve, and a flattened cortisol curve worsens sleep quality. The causal arrow runs in both directions. This is why addressing poor sleep without assessing cortisol leaves the most likely driver completely unexamined.
Optimal morning cortisol: 300 to 700 nmol/L measured at 8am, as part of a pattern assessment rather than a single snapshot. Reference ranges vary by laboratory; optimal timing and context matter as much as the number itself.
Aniva includes cortisol as a standard biomarker in its panel, alongside DHEA-S, which interacts directly with cortisol in the HPA axis stress response. If you've been told your cortisol is "fine" based on a single morning reading, that reading tells you less than you may think. Our full article on cortisol explains why a snapshot misses the curve →
Ferritin: The Restless Legs Connection Most Doctors Don't Make
Iron deficiency is the most prevalent nutritional gap in Europe. Among women of reproductive age, estimates of depleted iron stores run from 15% to 30%. The problem for sleep is specific and under-recognised. Low ferritin, which is the stored form of iron rather than haemoglobin, is among the strongest modifiable risk factors for Restless Legs Syndrome (RLS), a neurological condition characterised by an uncontrollable urge to move the legs that intensifies at rest and worsens in the evening.
RLS is not a minor inconvenience. It is a direct, mechanical cause of fragmented sleep. People with RLS take longer to fall asleep, wake more frequently during the night, and report significantly worse sleep quality and daytime function. The prevalence of RLS in Northern European populations runs as high as 10 to 19%, depending on diagnostic criteria used.
The iron connection operates through the brain's dopaminergic system. Iron is a required cofactor for dopamine synthesis in the central nervous system. When brain iron is insufficient, which can occur even when systemic ferritin is within the "normal" laboratory range, dopamine function is impaired, and RLS symptoms emerge or worsen. The RLS Foundation's Medical Advisory Board recommends targeting ferritin above 75 µg/L in RLS management. Most laboratory reference ranges flag ferritin as "low" only when it falls below 12 to 20 µg/L. The gap between 12 and 75 µg/L is where the problem lives. Ferritin in that range looks normal on paper while it is actively disrupting sleep.
A randomised, double-blind, placebo-controlled trial published in Sleep Medicine enrolled RLS patients with low-normal ferritin (mean 40.6 ng/mL), values that would typically be reported as normal. After 12 weeks of oral iron supplementation, the International Restless Legs Scale scores in the treatment arm fell by 10.3 points, compared to just 1.14 points in the placebo group (p=0.01). Restoring iron stores to a genuinely optimal range produced clinically meaningful improvement in sleep-disrupting symptoms.
The diagnostic gap here is structural. A großes Blutbild measures haemoglobin and red blood cell parameters. It does not measure ferritin. Haemoglobin is the last iron-dependent marker to fall. It declines only after iron stores are severely depleted. You can have significantly depleted ferritin, active RLS, and profoundly disrupted sleep while your haemoglobin reads perfectly within range. The most important marker for sleep-related iron status is precisely the one the standard blood count does not include.
Optimal ferritin for sleep and neurological function: 75 to 150 µg/L. Standard lab "normal" lower limit: 12 to 20 µg/L. The difference is not academic. It is the threshold at which symptoms appear.
Aniva tests ferritin alongside serum iron and transferrin saturation as standard, which is the full iron panel and not just the blood count. Our article on iron explains what your standard test is and isn't telling you →
Thyroid: The Circadian Regulator Nobody Tests for Sleep
TSH, thyroid-stimulating hormone, has its own circadian rhythm, one that is tightly coupled to sleep architecture. In a healthy pattern, TSH rises in the early evening, peaks during sleep, and falls in the morning. Sleep deprivation disrupts this rhythm. A 2010 randomised crossover trial by Kessler et al. found that partial sleep restriction produced modest but statistically significant declines in TSH and free T4, particularly in women. More recent work extended this finding: six weeks of restricting sleep to around 6 hours per night reduced TSH levels in women, effects consistent with a shift towards subclinical hypothyroidism driven by insufficient sleep rather than thyroid disease itself.
The reverse relationship is at least as clinically important. A large population-based study published in PMC compared sleep quality in 2,224 patients with subclinical hypothyroidism against 12,622 euthyroid controls. Subclinical hypothyroidism patients had significantly higher Pittsburgh Sleep Quality Index scores, longer sleep latency (p<0.001), and substantially greater sleep disturbance (p=0.001). Seven of eight studies in a subsequent 2024 systematic review reported a positive correlation between decreased sleep quality and subclinical hypothyroidism.
The mechanism is not fully established, but the evidence points to the suprachiasmatic nucleus, the brain's primary circadian pacemaker, as a key mediator. Thyroid hormones influence the expression of circadian clock genes. When thyroid function is impaired, even subclinically, circadian rhythm regulation may be disrupted in ways that a standard sleep history cannot detect and that a simple TSH reading may not fully capture.
Subclinical hypothyroidism, defined as an elevated TSH with normal free T4 and T3, is estimated to affect 4 to 8% of the adult population, with higher rates in women and in those over 60. Many cases are autoimmune in origin (Hashimoto's thyroiditis), and will not be detected without TPO antibody testing. A screening TSH alone can appear within the reference range while significant thyroid dysfunction is already present at the tissue level.
For sleep-related thyroid assessment, a full panel matters: TSH, free T4, free T3, and TPO antibodies. A TSH of 3.5 mIU/L with positive TPO antibodies tells a different story than a TSH of 3.5 mIU/L with no antibodies, even though the number is identical.
Magnesium: The Calming Mineral Most Germans Are Deficient In
Magnesium is involved in more than 300 enzymatic processes in the body. For sleep specifically, it acts on two converging pathways. First, it is a cofactor for the synthesis of serotonin, which is the precursor to melatonin, the hormone that signals darkness and initiates sleep. Second, magnesium activates GABA receptors, the same inhibitory neurotransmitter pathway that sleep medications target. In practical terms: adequate magnesium levels calm the nervous system and reduce the physiological arousal that keeps people awake.
European surveys consistently show that dietary magnesium intake falls below recommended levels in a significant proportion of the population, estimated at 30 to 50% of adults in Germany. The problem is compounded by modern agricultural practices that have reduced magnesium density in plant foods, and by factors that increase magnesium excretion: chronic stress, high alcohol intake, and some commonly prescribed medications.
A 2021 systematic review and meta-analysis published in BMC Complementary Medicine and Therapies pooled three randomised controlled trials and found that oral magnesium supplementation reduced sleep onset latency by 17.36 minutes compared to placebo (95% CI -27.27 to -7.44, p=0.0006). The evidence is assessed as low to very low quality by GRADE standards, because the trials were small and heterogeneous, but the directional signal is consistent: supplementing magnesium in deficient individuals improves the ability to fall asleep.
More recently, a 2025 German randomised controlled trial enrolled 155 adults with self-reported poor sleep and randomised them to magnesium bisglycinate (250mg elemental magnesium daily) or placebo for four weeks. The magnesium group showed significantly greater reductions in Insomnia Severity Index scores from baseline compared to placebo (-3.9 vs -2.3, p=0.049).
The standard clinical caveat applies: magnesium is difficult to assess from a blood test alone because serum magnesium reflects only about 1% of total body magnesium. Most magnesium is intracellular. Serum levels are tightly regulated and remain normal even as intracellular stores are depleted. A "normal" serum magnesium does not exclude functional deficiency. It is a reason to interpret the marker alongside other clinical indicators and dietary context.
Optimal serum magnesium: 0.85 to 1.0 mmol/L. Levels at the lower end of the reference range (0.7 to 0.85 mmol/L) may be associated with functional deficiency in the context of poor sleep, even when they register as technically "normal."
hs-CRP: When Inflammation Is the Reason You Cannot Get Deep Sleep
Chronic low-grade inflammation disrupts sleep architecture. It is not a metaphor or a hypothesis. It is a documented bidirectional relationship. Elevated high-sensitivity C-reactive protein (hs-CRP) predicts worse sleep quality, shorter slow-wave sleep, and more frequent nocturnal awakenings. Conversely, disrupted sleep raises inflammatory markers, including hs-CRP and pro-inflammatory cytokines, measurably so within a single night.
Research published in PMC found that chronically sleep-deprived individuals had significantly elevated hs-CRP at baseline compared to well-rested controls, alongside blunted morning cortisol and impaired executive function. The biological signature of chronic sleep deprivation was detectable in the blood, not just in subjective reports.
The mechanism involves the inflammatory cytokines IL-6 and TNF-α, which are elevated during sleep deprivation and which have direct effects on the central nervous system's sleep regulation. Elevated hs-CRP is the downstream marker of this process, the measurable result of a sustained inflammatory state that disrupts the architecture of sleep at the physiological level.
The practical implication: if you are experiencing poor sleep and have elevated hs-CRP, the relationship is likely bidirectional. The inflammation may be disrupting your sleep, and the poor sleep is likely worsening the inflammation. Treating only one without assessing the other misses half the loop.
hs-CRP is one of the most clinically informative and inexpensive markers available. Under 1.0 mg/L is low systemic risk. 1.0 to 3.0 mg/L is moderate, and worth investigating. Above 3.0 mg/L warrants clinical attention. It is not part of the großes Blutbild. It is not part of the Check-up 35. It is, like all four of the markers above, conspicuously absent from the standard preventive picture.
The Cascade Nobody Explains
These five markers do not operate independently. They form a cascade, a chain of interactions in which disruption in one amplifies dysfunction in the others.
It typically looks something like this. Low ferritin impairs dopamine synthesis, producing RLS symptoms that fragment sleep in the first half of the night. The fragmented sleep blunts the cortisol awakening response, producing a flat curve that fails to generate adequate morning alertness. Chronically disrupted sleep suppresses TSH and free T4, shifting thyroid function towards subclinical hypothyroidism. The impaired thyroid function slows circadian gene expression, worsening the circadian misalignment. The sleep deprivation, now multi-factorial, elevates hs-CRP, which directly suppresses slow-wave sleep and REM sleep. The elevated inflammation raises cortisol at the wrong time of day. The cycle reinforces itself.
This is why treating insomnia as a single-variable problem produces such consistently disappointing results. The sleep hygiene advice to limit screens, keep a consistent schedule, and reduce alcohol is not without value. But it is applied to a system that has multiple simultaneous dysregulations, without any of them being identified or addressed.
A blood test does not fix the cascade. But it identifies where the cascade is actually broken, which makes everything else more effective, and more targeted, and more likely to work.
What a GP Visit Can and Cannot Tell You About Your Sleep
The German statutory health system offers the Gesundheits-Check-up every three years from age 35. It tests four lipid values and a fasting glucose reading. That is it. None of the five markers discussed in this article are included. A großes Blutbild, which a GP can order with a medical indication, tests red and white blood cell parameters. It does not include ferritin, cortisol, thyroid markers, magnesium, or hs-CRP.
This is not a failing of individual doctors. The average GP consultation in Germany lasts 7 to 8 minutes. The Kassensystem was designed to catch and manage disease, not to conduct broad-spectrum preventive assessments in apparently healthy patients. A GP presented with a complaint of poor sleep will typically rule out obvious pathology, offer sleep hygiene advice, and potentially prescribe a short course of sedative medication. They will rarely order a panel that includes ferritin, a full thyroid screen with antibodies, magnesium, cortisol, and hs-CRP, even though this panel would, in many cases, identify the biological root cause of the problem.
There is also the interpretation gap. Even when markers are ordered, results are typically assessed against laboratory reference ranges, statistical norms derived from the general population. A ferritin of 18 µg/L is technically within some reference ranges and associated with significant neurological symptoms. A TSH of 3.8 mIU/L is "normal" but may indicate early autoimmune thyroid disease in the context of positive antibodies. The gap between "not pathological" and "actually optimal" is precisely where sleep-relevant dysfunction tends to live. We cover this structural gap in detail in our großes Blutbild guide →
Aniva tests all five of the biomarkers discussed in this article as part of its 100+ marker annual panel. That means cortisol, ferritin with the full iron panel, TSH with free T4, free T3 and TPO antibodies, magnesium, and hs-CRP. Results are interpreted against evidence-based optimal ranges, not just standard reference ranges, and delivered as a personalised report with actionable context. Get started with Aniva →
What You Can Actually Do
The practical framework is straightforward, even if it requires some persistence to execute within the German system.
First: test before supplementing. Magnesium supplements are inexpensive and broadly safe, but supplementing without a baseline is guessing. A ferritin of 110 µg/L needs no iron supplementation. A ferritin of 18 µg/L does. Treating both the same way, with a supplement you read about online, produces different outcomes for different reasons.
Second: request the full thyroid panel, not just TSH. TSH alone will miss impaired T4-to-T3 conversion, and will not detect early autoimmune thyroiditis without antibody testing. If your GP orders "thyroid function tests," ask specifically for free T4, free T3, and TPO antibodies alongside TSH.
Third: treat the results as a baseline, not a verdict. A single high hs-CRP reading taken during an active infection tells you nothing about your chronic inflammatory state. Magnesium levels require context. Cortisol requires interpretation relative to the time of the draw and the clinical picture. What makes these markers genuinely useful is tracking them over time, before and after interventions, to see what actually moves your sleep quality in a measurable direction.
Fourth: understand that the cascade means prioritisation matters. If ferritin is critically low, address that first. Cortisol dysregulation layered on top of unresolved iron deficiency will not improve until the iron is corrected. Sequence matters. Data makes sequencing possible. Our vitamin D article covers a similar principle, which is that the cofactor cascade requires the full picture and not one marker in isolation →
The Bottom Line
One third of German adults are sleeping badly. Sleep problems have risen 60% in a decade. The healthcare system's standard response is five values every three years, none of which address the biological drivers most commonly responsible for chronic sleep disruption.
The five markers that do address those drivers are cortisol, ferritin, thyroid function, magnesium, and hs-CRP. They are available, measurable, and interpretable. They are not exotic or experimental. They are simply not included in the default panel.
If your sleep is poor despite sensible habits, the question to ask is not "what should I try next?" It is: "what is actually dysregulated?" A blood test answers that question. Everything else is a guess.
Aniva's annual panel tests 100+ biomarkers, including all five covered in this article, at an ISO 15189-certified German laboratory, with results delivered as a personalised report. At €199 per year, it costs roughly the same as a single private GP consultation and provides the baseline a standard check-up never will.
Start your membership → | See the full biomarker list →
Sources
1. Schlack R, et al. "Frequency and distribution of sleep problems and insomnia in the adult population in Germany: results of DEGS1." Bundesgesundheitsblatt. 2013;56(5-6):740-748. edoc.rki.de
2. Marschall J, et al. "Gesundheitsreport 2017: Schlafstörungen." DAK-Gesundheit. 2017. dak.de
3. Wright KP Jr, et al. "Influence of Sleep Deprivation and Circadian Misalignment on Cortisol, Inflammatory Markers, and Cytokine Balance." PMC. 2015. PMC5401766
4. Czeisler CA, et al. Acute and Chronic Sleep Deprivation effects on biomarkers. PMC. 2021. PMC7854866
5. Wang J, O'Reilly B, Venkataraman R, et al. "Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study." Sleep Medicine. 2009;10(9):973-975. PubMed
6. Song TJ, et al. "The Association Between Subclinical Hypothyroidism and Sleep Quality: A Population-Based Study." PMC. 2019. PMC6927586
7. Kessler L, Nedeltcheva A, Imperial J, Penev PD. "Changes in serum TSH and free T4 during human sleep restriction." Sleep. 2010;33(8):1115-1118. PubMed
8. Mah J, Pitre T. "Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis." BMC Complementary Medicine and Therapies. 2021;21(1):125. PMC8053283
9. Magnesium bisglycinate supplementation in healthy adults reporting poor sleep: a Randomized, Placebo-Controlled Trial. PMC. 2025. PMC12412596
10. Teliti M, et al. "The interplay between subclinical hypothyroidism and poor sleep quality: a systematic review." European Journal of Internal Medicine. 2024;126:49-55. ejinme.com
This content is for informational purposes only and is not medical advice. Always discuss results with a qualified healthcare professional.
